Evkeeza (evinacumab or evinacumab-dgnb) is a monoclonal antibody that treats homozygous familial hypercholesterolemia (HoFH), a rare genetic condition that causes extremely high cholesterol levels. It's an add-on medication for adults and children aged 5 years and older who aren't able to reach their cholesterol goals even with diet changes and other medications. Evkeeza (evinacumab) is given as an infusion through the veins (IV) once a month. Side effects can include dizziness and cold- or flu-like symptoms.
Homozygous familial hypercholesterolemia (HoFH) in people 5 years and older, taken with other cholesterol-lowering medications
Evkeeza (evinacumab) is a monoclonal antibody that works as an angiopoietin-like 3 (ANGPTL3) inhibitor. ANGPTL3 is a protein in your liver that normally stops your body from getting rid of triglycerides (fat) and low-density lipoprotein (LDL, also known as “bad” cholesterol). By blocking the ANGPTL3 protein, Evkeeza (evinacumab) allows your body to break down and remove triglycerides and LDL.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
A new type of medication for the treatment of HoFH
Only one infusion every month
Can use if you have mild or moderate kidney problems
No special diet needed to start the medication; can continue eating a heart-healthy diet
Only available as an IV infusion given by a healthcare provider
Each infusion takes one hour
Might not be safe during pregnancy
Only available as a brand-name medication
Evkeeza (evinacumab) is given as an IV infusion by trained healthcare providers in a clinic or infusion center or sometimes even at home. Discuss with your provider to find an option that works best for you.
Set reminders for your appointments, and tell a loved one when your Evkeeza (evinacumab) infusions are scheduled. This can help make sure you don't miss a dose. But if you do, reschedule your appointment right away. The rest of your infusions will be scheduled every month from the day you had your last infusion.
Be sure to get any blood tests that your provider orders on time. These blood tests make sure that Evkeeza (evinacumab) is working well to lower your cholesterol levels.
Your healthcare team will watch out for side effects that you might have, such as cold-like symptoms, nausea, and any allergic reactions, during and after your Evkeeza (evinacumab) infusion.
Your provider might recommend or give you ibuprofen (Advil) or antihistamines to help with mild allergic reactions like flushing, headache, and rash. Get medical help as soon as possible if you have trouble breathing or swelling of the face or tongue, since these are signs of a more serious allergic reaction.
If you can become pregnant, you should use birth control during treatment and for at least 5 months after your last dose of Evkeeza (evinacumab). This medication can cause harm to an unborn baby. Consult with your provider to determine the best birth control options for you. And let your provider know right away if you become pregnant during treatment.
Evkeeza (evinacumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Though rare, it's possible to have a serious allergic reaction to Evkeeza (evinacumab). These allergic reactions can include anaphylaxis (closing of the throat), hives, trouble breathing, and swelling of the face or tongue. Your nurse will watch out for allergic reactions during your infusion, but be sure to tell your care team right away if you think you're having an allergic reaction to the medication. Call 911 if it happens after you've left the infusion center or clinic or when you're at home.
Risk factors: Currently pregnant
Based on findings from animal studies, Evkeeza (evinacumab) can cause birth defects when it's used during pregnancy. If you’re a woman who can have children, your provider might ask you to take a pregnancy test to make sure you're not pregnant before you start treatment. You'll need to also use reliable birth control during treatment and for at least 5 months after your last dose of Evkeeza (evinacumab). Let your provider know if you’re planning to become pregnant or are currently pregnant. Your provider will help you find safer ways to lower your cholesterol.
Evkeeza (evinacumab) is an intravenous (IV) infusion that's given by a healthcare provider. The typical dose is based on your body weight at 15 mg/kg that's infused IV once a month.
Homozygous familial hypercholesterolemia (HoFH) in people 5 years and older, taken with other cholesterol-lowering medications
High cholesterol in adults
Inherited condition causing extremely high cholesterol (heterozygous and homozygous familial hypercholesterolemia) in people aged 10 years and older
Lower the risk of heart attack, stroke, and the need for heart procedures (like stent placement) in adults with known heart disease
By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.
American College of Allergy, Asthma, and Immunology. (2018). Drug allergies.
American Heart Association. (2023). What is familial hypercholesterolemia?
Lim, G. B. (2017). ANGPTL3: A therapeutic target for atherosclerosis. Nature Reviews Cardiology.
Lui, D. T. W., et al. (2020). Management of familial hypercholesterolemia: Current status and future perspectives. Journal of the Endocrine Society.
McGowan, M. P., et al. (2019). Diagnosis and treatment of heterozygous familial hypercholesterolemia. Journal of the American Heart Association.
Price Lundberg, G., et al. (2018). Familial hypercholesterolemia and pregnancy. American College of Cardiology.
Regeneron Pharmaceuticals, Inc. (2023). Evkeeza- evinacumab injection, solution, concentrate [package insert]. DailyMed.
Regeneron Pharmaceuticals, Inc. (2023). FDA approves first-in-class Evkeeza® (evinacumab-dgnb) for young children with ultra-rare form of high cholesterol. Globe Newswire.
Regeneron Pharmaceuticals, Inc. (2023). Your doctor has prescribed you Evkeeza® (evinacumab-dgnb): What happens next?
Sosnowska, B., et al. (2023). Evinacumab, an ANGPTL3 inhibitor, in the treatment of dyslipidemia. Journal of Clinical Medicine.
U.S. Food and Drug Administration. (2021). FDA approves add-on therapy for patients with genetic form of severely high cholesterol.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.